HCG Manavata Cancer Centre is a renowned Health Care startup based in India, established in 2006. The center has achieved numerous milestones, including being the first NABH Accredited Cancer Hospital in Maharashtra and treating over 150,000 patients in its 17-year journey. It boasts state-of-the-art infrastructure, a team of expert super specialists, and has garnered recognition, including the "International Healthcare Award 2016" for being the "Most Promising Cancer Centre in Maharashtra." HCG Manavata Cancer Centre is also in line to become the 1st NABH accredited Cancer hospital in Western India. The center offers complete and comprehensive cancer care, ranging from surgical oncology to preventive oncology, clinical nutrition, and physiotherapy. Additionally, the center's Research facility, Manavata Clinical Research Institute (MCRI), has been audited by US-FDA & DCGI, adding to its credibility. The startup's commitment to excellence has been acknowledged with a nomination for the "Best Healthcare Provider" and receiving an ISO Certification. With its stellar track record, groundbreaking treatments, and commitment to patient care, HCG Manavata Cancer Centre stands as a leading force in the fight against cancer in India. For further information, interested parties can visit www.hcgmanavatacancer.org.
There is no investment information